The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Non–Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging
Abstract
PURPOSE: To determine the accuracy of dual-modality positron emission tomographic (PET)-computed tomographic (CT) imaging, as compared with PET alone and CT alone, in the staging of non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Twenty-seven patients with NSCLC underwent staging with combined fluorine 18 fluorodeoxyglucose PET and CT. CT, PET, and coregistered PET/CT images were evaluated separately by two different physicians for each imaging modality, and disease stage was determined by using TNM and American Joint Committee on Cancer staging systems. Histopathologic results served as the reference standard. The statistical significance of differences among CT, PET, and PET/CT was determined by using the McNemar test. RESULTS: Overall tumor stage was correctly classified as 0-IV with CT in 19 patients, with PET in 20 patients, and with PET/CT in 26 patients. PET/CT findings when compared with PET findings led to a treatment change for four patients (15%) and when compared with CT findings led to a treatment change for five patients (19%). Differences in the accuracy of overall tumor staging between PET/CT and CT (P =.008) and between PET/CT and PET (P =.031) were significant. Primary tumor stage was correctly determined in more patients with PET/CT than with either PET alone or CT alone. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of regional lymph node staging, respectively, were 89%, 94%, 89%, 94%, and 93%, with PET/CT; 89%, 89%, 80%, 94%, and 89% with PET; and 70%, 59%, 50%, 77%, and 63% with CT. Fourteen distant metastases were detected in four patients with CT, four were detected in two patients with PET, and 17 were detected in four patients with PET/CT. CONCLUSION: Use of dual-modality PET/CT significantly increases the number of patients with correctly staged NSCLC and thus has a positive effect on treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
A combined PET/CT scanner for clinical oncology.
Beyer, T., Townsend, D. W., Brun, T., Kinahan, P. E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L. G., & Nutt, R. (2000) · PubMed · Cited by 1,659
Self-citationPreoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
Pieterman, R. M., van Putten, J. W. G., Meuzelaar, J. J., Mooyaart, E. L., Vaalburg, W., Koëter, G. H., Fidler, V., Pruim, J., & Groen, H. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430404 · Cited by 1,111
Gould, M. K., Maclean, C. C., Kuschner, W. G., Rydzak, C. E., & Owens, D. K. (2001) · JAMA · doi:10.1001/jama.285.7.914 · Cited by 1,094
Attenuation correction for a combined 3D PET/CT scanner
Kinahan, P. E., Townsend, D. W., Beyer, T., & Sashin, D. (1998) · Medical Physics · doi:10.1118/1.598392 · Cited by 946
Self-citationDwamena, B. A., Sonnad, S. S., Angobaldo, J. O., & Wahl, R. L. (1999) · Radiology · doi:10.1148/radiology.213.2.r99nv46530 · Cited by 649
Prognostic Factors in Non-small Cell Lung Cancer
Brundage, M. D., Davies, D., & Mackillop, W. J. (2002) · Chest · doi:10.1378/chest.122.3.1037 · Cited by 564
Huang, (. S.-C. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00155-4 · Cited by 458
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Marom, E. M., McAdams, H. P., Erasmus, J. J., Goodman, P. C., Culhane, D. K., Coleman, R. E., Herndon, J. E., & Patz, E. F. (1999) · Radiology · doi:10.1148/radiology.212.3.r99se21803 · Cited by 384
Detection of extrathoracic metastases by positron emission tomography in lung cancer
Weder, W., Schmid, R. A., Bruchhaus, H., Hillinger, S., von Schulthess, G. K., & Steinert, H. C. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00675-4 · Cited by 231
Relevance of Positron Emission Tomography (PET) in Oncology
Weber, W., Avril, N. E., & Schwaiger, M. (1999) · Strahlentherapie und Onkologie · doi:10.1007/s000660050022 · Cited by 148
Dual-modality PET/CT tomography for clinical oncology.
Beyer, T., Townsend, D. W., & Blodgett, T. M. (2002) · PubMed · Cited by 137
Self-citationOptimum scanning protocol for FDG-PET evaluation of pulmonary malignancy
Lowe, V. J. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90601-0 · Cited by 133
A combined PET/CT scanner: the choices.
Townsend, D. W. (2001) · PubMed · Cited by 119
Whole-Body Positron Emission Tomography—CT: Optimized CT Using Oral and IV Contrast Materials
Antoch, G., Freudenberg, L. S., Stattaus, J., Jentzen, W., Müeller, S., Debatin, J. F., & Bockisch, A. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.6.1791555 · Cited by 117
Self-citationGupta, N. C., Graeber, G. M., Rogers, J. S., & Bishop, H. A. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00018 · Cited by 115
Quantitating tumor glucose metabolism with FDG and PET.
Hawkins, R. A., Choi, Y. H., Huang, S., Messa, C., Hoh, C. K., & Phelps, M. E. (1992) · PubMed · Cited by 76
Cost considerations regarding an integrated CT-PET system
von Schulthess, G. K. (2000) · European Radiology · doi:10.1007/pl00014098 · Cited by 59
Improved mammographic interpretation of masses using computer-aided diagnosis
Leichter, I. S., Fields, S. I., Nirel, R., Bamberger, P., Novak, B., Lederman, R. J., & Buchbinder, S. S. (2000) · European Radiology · doi:10.1007/s003300050059 · Cited by 31
Cited by
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Methods for Staging Non-small Cell Lung Cancer
Silvestri, G. A., Gonzalez, A. V., Jantz, M. A., Margolis, M. L., Gould, M. K., Tanoue, L. T., Harris, L. J., & Detterbeck, F. C. (2013) · Chest · doi:10.1378/chest.12-2355 · Cited by 1,483
Recommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Gridelli, C., Rossi, A., Carbone, D. P., Guarize, J., Karachaliou, N., Mok, T., Petrella, F., Spaggiari, L., & Rosell, R. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.9 · Cited by 1,083
Noninvasive Staging of Non-small Cell Lung Cancer*
Toloza, E. M., Harpole, L., & McCrory, D. C. (2003) · Chest · doi:10.1378/chest.123.1_suppl.137s · Cited by 745
Metadata
- Authors
- Antoch, G., Stattaus, J., Nemat, A. T., Marnitz, S., Beyer, T., Kuehl, H., Bockisch, A., Debatin, J. F., & Freudenberg, L. S.
- Venue
- Radiology
- Published
- 2003-11
- Volume
- 229
- Issue
- 2
- Pages
- 526-533
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2150992047
- Cited by
- 540
- References
- 19
- FWCI
- 32.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.